Difference between revisions of "Team:UCL/Safety"
Superjack15 (Talk | contribs) |
Superjack15 (Talk | contribs) |
||
Line 95: | Line 95: | ||
content: ""; | content: ""; | ||
background-image: url('https://static.igem.org/mediawiki/2015/e/e7/UCL_MG_6312_2.png'); | background-image: url('https://static.igem.org/mediawiki/2015/e/e7/UCL_MG_6312_2.png'); | ||
+ | -webkit-filter: opacity(60%) blur(0.5px); | ||
+ | -moz-filter: blur(2px); | ||
+ | -o-filter: blur(2px); | ||
+ | -ms-filter: blur(2px); | ||
+ | filter: blur(2px); | ||
background-repeat: no-repeat; | background-repeat: no-repeat; | ||
background-attachment: fixed !important; | background-attachment: fixed !important; |
Revision as of 20:39, 18 September 2015
'
B12 riboswitch
In order to address safety issues associated with our psychobiotics, we have developed a unique B12 riboswitch-mediated
containment strategy
▼